ANN PORTER: Open Payments
NPI 1053019018 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 18 payments from 11 companies in 2025. Trend: 2023 $1,195 · 2024 $2,459 · 2025 $679
| Company | Payments | Amount |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 5 | $199 |
| Endologix LLC | 2 | $170 |
| Penumbra, Inc. | 2 | $75 |
| Boston Scientific Corporation | 2 | $58 |
| Organogenesis Inc. | 1 | $52 |
| CARDIVA MEDICAL, INC. | 1 | $28 |
| Integra LifeSciences Corporation | 1 | $27 |
| Abbott Laboratories | 1 | $22 |
| Ethicon US, LLC | 1 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
Products named: AFX2 Bifurcated Endograft System, LUTONIX Drug Coated Balloon, GlidePath, PURAPLY WOUND MATRIX, Penumbra System, Alto Abdominal Stent Graft System, ENROUTE Transcarotid Neuroprotection System, Venovo.
Industry payments across NE — which companies pay providers there.
